Sanofi's Four-strain Influenza Vaccine Approved by FDA

Source: PharmaManufacturing.com

Jun 10, 2013

Reuters

French drugmaker Sanofi SA said the U.S. Food and Drug Administration had approved its four-strain influenza vaccine, which is meant to provide better protection from infection than traditional three-strain flu vaccines.

The Fluzone Quadrivalent vaccine is licensed for adults, adolescents and children 6 months and older, and will be available in the upcoming 2013-2014 flu season, the company said on Monday.

The 2013 influenza season will be the first when quadrivalent influenza vaccines will be available in the United States. Read the full story.